DOCSLIB.ORG

Abnormal Uterine Bleeding Sorting It All

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abnormal Uterine Bleeding Sorting It All Abnormal Uterine Bleeding- Sorting It All Out Patricia Geraghty MSN, FNP-BC, WHNP Disclosures • Abbvie Inc. Speakers Bureau, Advisory Board • Therapeutics MD Speaker, Advisory Board • Sharecare Inc. Advisory Board • No commercial material is included in this presentation. All citations are from peer-reviewed academic sources. The speaker has not been paid by any outside entity for this presentation or any presentation on this topic. Objectives • Define the variation in normal uterine bleeding. • Distinguish the etiology of abnormal uterine bleeding according to the PALM-COEIN classification system. • Determine age appropriate approach to the diagnostic work- up of abnormal uterine bleeding. • Select the management strategies for specific abnormal bleeding etiology utilizing an understanding of structural and hormonal interventions. • Differentiate the interventions for acute heavy uterine bleeding. Defining Normal • Normal menses (95% of population)1 • Frequency every 24 to 38 days • Duration 4 to 6 days • Blood volume 20-80 cc; requires change of protection every 3 to 6 hours on heaviest day(s) • Tapers over following days • 50% volume loss is vaginal and cervical secretions • Regular -difference between longest and shortest interval < 20 days in 12 month period 1Fraser I, et al. Fertil Steril. 2007;87(3):466-476. ACOG Committee Practice Bulletin. Ob Gyn. 2012; 120(1):197-206. Sharp HT, Johnson JV et al. Obstet Gynecol. 2017 Apr;129(4):603-607 Updating Terminology Dimension < 5th Percentile 5th-95th Percentile >95th Percentile Regularity cycle- Absent Regular (variation Irregular (typical variation to-cycle over 12 Amenorrhea 2 ± 20d) >20d between mos longest/shortest interval) Intermenstrual Frequency Infrequent (>38d) Normal Frequent (<24d) Oligomenorrhea Polymenorrhea Duration Shortened (< 4.5d) Normal Prolonged (> 8d) Hypomenorrhea Hypermenorrhea Volume Light (< 5 cc) Normal Heavy (> 80 cc) Hypomenorrhea Menorrhagia Combination Irregular and Heavy Menometrorrhagia Sharp HT, Johnson JV et al. Obstet Gynecol. 2017 Apr;129(4):603-607 Abnormal Uterine Bleeding Etiology & Pattern: PALM-COEIN FIGO Classification System Abnormal Uterine Bleeding (AUB) Coagulopathy Polyp Systemic Ovulatory dysfunction Adenomyosis Endometrial eiomyoma Structural L Iatrogenic Malignancy & hyperplasia Not yet classified Munro MC, Critchley HOD, Broder MS, et al. Int J Gyn Ob. 2011;113:3-13. Definitions • Polyp- endometrial or endocervical • Typically asymptomatic but may contribute to AUB • Typically histology benign w/only small fraction malignant • Detected via ultrasound and hysteroscopic imaging • Adenomyosis- endometrial cells w/in the myometrium • Link to AUB unclear w/increasingly heavy bleeding and pain • Traditional dx histopathology s/p hysterectomy but now diagnostic criteria through ultrasound or MRI • Leiomyoma- benign fibromuscular tumor of myometrium • Location, number and size • Relationship to endometrium and serosa affects AUB • Malignancy and Hyperplasia Munro MC, Critchley HOD, Broder MS, et al. Int J Gyn Ob. 2011;113:3-13. • Coagulopathy- systemic disorders of hemostasis • Etiology of 13% of heavy menstrual bleeding (HMB) • Include anticoagulation therapy HMB here • Ovulatory dysfunction- unpredictable timing, variable flow of which some are HMB • Many r/t endocrinopathies (PCOS, hypothyroid, hyperprolactinemia, mental stress, obesity, anorexia, weight loss, extreme exercise) • Endometrial- HMB in presence of regular ovulatory cycles and no other identifiable etiology • Documented deficiencies vasoconstrictors (endothelin-1, prostaglandin F2α), accelerated endometrial clot lysis (excess plasminogen activator)or excess local production vasodilators. • No clinical tests available; dx of exclusion Munro MC, Critchley HOD, Broder MS, et al. Int J Gyn Ob. 2011;113:3-13. • Iatrogenic- caused by medical intervention or device • Direct impact on endometrium, blood coagulation or systemic control of ovulation • Unscheduled bleeding aka break through bleeding (BTB) while on gonadal steriods • Effect both the HPO axis and the endometrium directly • Missed/delayed doses • Drug effect: anticonvulsants, rifampin & griseofulvin, cigarettes • Dopamine metabolism effects (tricyclic antidepressants, phenothiazines) reduce serotonin uptake and inhibit prolactin release. • Any SSRI can cause ovulatory dysfunction w/amenorrhea or irregular • Not yet classified- connection unclear or not yet identified Cycle The Menstrual • Ovarian follicular phase- follicle develops in response to FSH from the pituitary and secretes estrogen. Estrogen stimulates growth, or proliferation of the endometrium. • Ovulation- High levels of estrogen trigger LH from the pituitary, which causes ovulation. The follicular structure becomes the corpus luteum, and secretes progesterone. • Ovarian luteal phase- Progesterone halts growth and causes maturation of the endometrium. The endometrium becomes secretory. The corpus luteum degenerates over 14 days. Estrogen and progesterone levels fall, triggering increase in FSH. Managment Acute Heavy Menstrual Bleeding • Estrogen/Progesterone Sequential • Conjugated estrogen 10 mg (2.5mg po q 6h) to cause rapid growth of endometrium over denuded basalis • Controls bleeding within 24 hours • May need antiemetic • Alternate IV estrogen 20-25 mg every 3-4 hours x 24 hours • After bleeding slows dramatically (12-24 hours), add progestin MPA 5-10 mg to stabilize endometrium • Continue both estrogen and progestin for 7 to 10 days • Close follow up Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Lippincott, Williams & Wilkins. 2011. Alternate Protocol Acute HMB • Estrogen/Progesterone Combined • High dose birth control pill (Norgestrel 0.5mg/EE 50 mcg; Ovral®) • 1 Tablet PO Q 12h x 5-7 days, then 1 tablet QD to finish pill pack. • May taper sooner if bleeding is controlled, and if patient complains of side effects • One study found this protocol less effective than sequential but compliance was better • Follow up 7-21 days • Continue Norgestrel 0.5 mg/EE 50 mcg or Conjugated estrogen 2.5mg PO with MPA 5-10 mg • Begin diagnostic work up Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Lippincott, Williams & Wilkins. 2011. Management Acute Heavy Bleeding With Concerns About Estrogen Use High Dose Progestin Treatments for Acute Uterine Bleeding (n=40) MPA 20 mg 3 times Norethindrone 1 mg/EE daily x 7 days, then 35 mcg 3 times daily x 7 once daily x 3 weeks days, then once daily x 3 weeks No Surgery 100% 95% Cessation of Bleeding 76% 88% Days to Cessation 3 3 Patient Satisfaction 0-4 3 3 0 = unsatisfied Munro MG, et al. Obstet Gynecol. 2006; 108(4): 924-29. Acute Bleeding Tranexamic Acid • Anti-fibrinolytic • Data from CRASH-2 (trauma) and WOMAN (obstetrical hemorrhage) extrapolated to other acute bleeding OFF LABEL • 1 g (100 mg/ml) at 1 ml/min IV • Only effective if initiated within first 3 hours of bleeding in PP hemorrhage • Meets ACOG guidelines for therapy CRASH-2 Collaborators. Lancet. 2010;376:23–32. WOMAN Trial Collaborators. Lancet. 2017 May 27; 389(10084): 2105–2116. ACOG Committee Opinion 557. Obstet Gynecol. 2013 Apr;121(4):891-6. ACOG Committee Opinion 785. Obstet Gynecol. 2019; 134(3)e71-83. Approach to Work-up Abnormal Uterine Bleeding (AUB) Coagulopathy Systemic Polyp Ovulatory dysfunction Adenomyosis Endometrial Leiomyoma Structural Iatrogenic Malignancy & hyperplasia Not yet classified Munro MC, Critchley HOD, Broder MS, et al. Int J Gyn Ob. 2011;113:3-13. Parameters for Evaluation • Evaluate any woman with • Cycles < 24 days or > 38 days • Duration > 7 days • Volume > 80 ml • Evaluate any woman whose perception of her cycles is that of interfering with typical daily activities or of causing concern • Deviations from individual’s established pattern • AAP and ACOG call the menstrual cycle a “vital sign” in adolescents • Cycles established within 3 years of menarche; evaluate any change, evaluate any pattern of cycles > 90 days ACOG Committee on Adolescent Medicine Opinion No. 349. Obstet Gynecol. 2006:180(5):1323- 28. AAP Committee on Adolescence , et al. Pediatrics. 2006; 118(5): 2245050. 19 y with HMB and Irregularity • She reports irregular cycle length of 14 to 60 days • Both flow and duration vary from 5-10 days of light spotting to 4 days heavy bleeding followed by spotting. • The heavy flow days require changing protection every 2 hours • There are no temporal associations (post-coital, post-pill, weight gain or loss) • She has associated symptoms of cystic acne and complains it is harder for her to maintain her weight than for her friends • She is not on any medications and denies tobacco use. • She is not sexually active and STD screen is up to date. 19 y with HMB and Irregularity FIGO Classification System Abnormal Uterine Bleeding (AUB) Coagulopathy Systemic Polyp Ovulatory dysfunction Adenomyosis Endometrial Leiomyoma Structural Iatrogenic Malignancy & hyperplasia Not yet classified Munro MC, Critchley HOD, Broder MS, et al. Int J Gyn Ob. 2011;113:3-13. Ovulatory Dysfunction • Physiologic unopposed estrogen causes heavy but unstable endometrium • Irregular heavy bleeding w/o typical moliminal symptoms mixed with spotting d/t partial endometrial sloughing • Life stage is most common contributing factor • Menarche followed by 2 to 3 years of infrequent cycles • Early perimenopause (age 40-42) frequent and heavy cycles • Late perimenopause cycles infrequent, flow is variable Polycystic Ovarian Syndrome (PCOS) • Increased peripheral aromatization of
Load more

Recommended publications
  • The Male Reproductive System
    Management of Men’s Reproductive 3 Health Problems Men’s Reproductive Health Curriculum Management of Men’s Reproductive 3 Health Problems © 2003 EngenderHealth. All rights reserved. 440 Ninth Avenue New York, NY 10001 U.S.A. Telephone: 212-561-8000 Fax: 212-561-8067 e-mail: [email protected] www.engenderhealth.org This publication was made possible, in part, through support provided by the Office of Population, U.S. Agency for International Development (USAID), under the terms of cooperative agreement HRN-A-00-98-00042-00. The opinions expressed herein are those of the publisher and do not necessarily reflect the views of USAID. Cover design: Virginia Taddoni ISBN 1-885063-45-8 Printed in the United States of America. Printed on recycled paper. Library of Congress Cataloging-in-Publication Data Men’s reproductive health curriculum : management of men’s reproductive health problems. p. ; cm. Companion v. to: Introduction to men’s reproductive health services, and: Counseling and communicating with men. Includes bibliographical references. ISBN 1-885063-45-8 1. Andrology. 2. Human reproduction. 3. Generative organs, Male--Diseases--Treatment. I. EngenderHealth (Firm) II. Counseling and communicating with men. III. Title: Introduction to men’s reproductive health services. [DNLM: 1. Genital Diseases, Male. 2. Physical Examination--methods. 3. Reproductive Health Services. WJ 700 M5483 2003] QP253.M465 2003 616.6’5--dc22 2003063056 Contents Acknowledgments v Introduction vii 1 Disorders of the Male Reproductive System 1.1 The Male
    [Show full text]
  • Prolactin Level in Women with Abnormal Uterine Bleeding Visiting Department of Obstetrics and Gynecology in a University Teaching Hospital in Ajman, UAE
    Prolactin level in women with Abnormal Uterine Bleeding visiting Department of Obstetrics and Gynecology in a University teaching hospital in Ajman, UAE Jayakumary Muttappallymyalil1*, Jayadevan Sreedharan2, Mawahib Abd Salman Al Biate3, Kasturi Mummigatti3, Nisha Shantakumari4 1Department of Community Medicine, 2Statistical Support Facility, CABRI, 4Department of Physiology, Gulf Medical University, Ajman, UAE 3Department of OBG, GMC Hospital, Ajman, UAE *Presenting Author ABSTRACT Objective: This study was conducted among women in the reproductive age group with abnormal uterine bleeding (AUB) to determine the pattern of prolactin level. Materials and Methods: In this study, a total of 400 women in the reproductive age group with AUB attending GMC Hospital were recruited and their prolactin levels were evaluated. Age, marital status, reproductive health history and details of AUB were noted. SPSS version 21 was used for data analysis. Descriptive statistics was performed to describe the population, and inferential statistics such as Chi-square test was performed to find the association between dependent and independent variables. Results: Out of 400 women, 351 (87.8%) were married, 103 (25.8%) were in the age group 25 years or below, 213 (53.3%) were between 26-35 years and 84 (21.0%) were above 35 years. Mean age was 30.3 years with a standard deviation 6.7. The prolactin level ranged between 15.34 mIU/l and 2800 mIU/l. The mean and SD observed were 310 mIU/l and 290 mIU/l respectively. The prolactin level was high among AUB patients with inter-menstrual bleeding compared to other groups. Additionally, the level was high among women with age greater than 25 years compared to those with age less than or equal to 25 years.
    [Show full text]
  • Endometriosis for Dummies.Pdf
    01_050470 ffirs.qxp 9/26/06 7:36 AM Page i Endometriosis FOR DUMmIES‰ by Joseph W. Krotec, MD Former Director of Endoscopic Surgery at Cooper Institute for Reproductive Hormonal Disorders and Sharon Perkins, RN Coauthor of Osteoporosis For Dummies 01_050470 ffirs.qxp 9/26/06 7:36 AM Page ii Endometriosis For Dummies® Published by Wiley Publishing, Inc. 111 River St. Hoboken, NJ 07030-5774 www.wiley.com Copyright © 2007 by Wiley Publishing, Inc., Indianapolis, Indiana Published by Wiley Publishing, Inc., Indianapolis, Indiana Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permit- ted under Sections 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400, fax 978-646-8600. Requests to the Publisher for permission should be addressed to the Legal Department, Wiley Publishing, Inc., 10475 Crosspoint Blvd., Indianapolis, IN 46256, 317-572-3447, fax 317-572-4355, or online at http:// www.wiley.com/go/permissions. Trademarks: Wiley, the Wiley Publishing logo, For Dummies, the Dummies Man logo, A Reference for the Rest of Us!, The Dummies Way, Dummies Daily, The Fun and Easy Way, Dummies.com, and related trade dress are trademarks or registered trademarks of John Wiley & Sons, Inc., and/or its affiliates in the United States and other countries, and may not be used without written permission.
    [Show full text]
  • Prevalence of Menstrual Irregularities in Correlation with Body Fat Among Students of Selected Colleges in a District of Tamil Nadu, India
    National Journal of Physiology, Pharmacy and Pharmacology RESEARCH ARTICLE Prevalence of menstrual irregularities in correlation with body fat among students of selected colleges in a district of Tamil Nadu, India Sherly Deborah G1, Siva Priya D V2, Rama Swamy C2 1Department of Physiology, Faculty of Medicine, AIMST University, Bedong, Kedah, Malaysia, 2Department of Physiology, Saveetha Medical College, Chennai, Tamil Nadu, India Correspondence to: Sherly Deborah G, E-mail: [email protected] Received: March 05, 2017; Accepted: March 22, 2017 ABSTRACT Background: Menstrual irregularities are usually due to imbalance of hormones. Although menstrual irregularities may be normal during the early postmenarchal years, pathological conditions require proper and prompt management. Obesity associated with many health consequences including hormonal imbalance has a direct effect on menstrual cycle. Hence, attention to obesity is obligatory for the inclusion of diagnosis and treatment of menstrual complaints which has become a leading issue in women’s life. Aims and Objectives: The aims and objectives of the study are to assess the menstrual irregularities and to find the association between menstrual irregularities and body fat among students. Materials and Methods: A cross-sectional study was conducted in three selected colleges in a district of Tamil Nadu in India. A total of 399 samples were included in the study. A 10-item questionnaire was administered to assess the menstrual irregularity in each student. The demographic variables along with anthropometric measurements were collected. Anthropometric measurements were taken to calculate the body fat percentage using modified YMCA formula. Results: The prevalence of menstrual irregularities was high in obesity compared with those with normal body fat and particularly oligomenorrhea, amenorrhea, and hypomenorrhea had statistically significant increase in obese students.
    [Show full text]
  • (IJCRI) Abdominal Menstruation
    www.edoriumjournals.com CASE SERIES PEER REVIEWED | OPEN ACCESS Abdominal menstruation: A dilemma for the gynecologist Seema Singhal, Sunesh Kumar, Yamini Kansal, Deepika Gupta, Mohit Joshi ABSTRACT Introduction: Menstrual fistulae are rare. They have been reported after pelvic inflammatory disease, pelvic radiation therapy, trauma, pelvic surgery, endometriosis, tuberculosis, gossypiboma, Crohn’s disease, sepsis, migration of intrauterine contraceptive device and other pelvic pathologies. We report two rare cases of menstrual fistula. Case Series: Case 1: A 27- year-old nulliparous female presented with complaint of cyclical bleeding from the abdomen since three years. There was previous history of hypomenorrhea and cyclical abdominal pain since menarche. There is history of laparotomy five years back and laparoscopy four years back in view of pelvic mass. Soon after she began to have blood mixed discharge from scar site which coincided with her menstruation. She was diagnosed to have a vertical fusion defect with communicating left hypoplastic horn and non-communicating right horn on imaging. Laparotomy with excision of fistula and removal of right hematosalpinx was done. Case 2: 25-year-old female presented with history of lower segment caesarean section (LSCS) and burst abdomen, underwent laparotomy and loop ileostomy. Thereafter patient developed cyclical bleeding from scar site. Laparotomy with excision of fistulous tract and closure of uterine rent was done. Conclusion: Clinical suspicion and imaging help to clinch the diagnosis. There is no recommended treatment modality. Surgery is the mainstay of management. Complete excision of fistulous tract is mandatory for good long-term outcomes. International Journal of Case Reports and Images (IJCRI) International Journal of Case Reports and Images (IJCRI) is an international, peer reviewed, monthly, open access, online journal, publishing high-quality, articles in all areas of basic medical sciences and clinical specialties.
    [Show full text]
  • Vaginitis and Abnormal Vaginal Bleeding
    UCSF Family Medicine Board Review 2013 Vaginitis and Abnormal • There are no relevant financial relationships with any commercial Vaginal Bleeding interests to disclose Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine [email protected] Vulvovaginal Symptoms: CDC 2010: Trichomoniasis Differential Diagnosis Screening and Testing Category Condition • Screening indications – Infections Vaginal trichomoniasis (VT) HIV positive women: annually – Bacterial vaginosis (BV) Consider if “at risk”: new/multiple sex partners, history of STI, inconsistent condom use, sex work, IDU Vulvovaginal candidiasis (VVC) • Newer assays Skin Conditions Fungal vulvitis (candida, tinea) – Rapid antigen test: sensitivity, specificity vs. wet mount Contact dermatitis (irritant, allergic) – Aptima TMA T. vaginalis Analyte Specific Reagent (ASR) Vulvar dermatoses (LS, LP, LSC) • Other testing situations – Vulvar intraepithelial neoplasia (VIN) Suspect trich but NaCl slide neg culture or newer assays – Psychogenic Physiologic, psychogenic Pap with trich confirm if low risk • Consider retesting 3 months after treatment Trichomoniasis: Laboratory Tests CDC 2010: Vaginal Trichomoniasis Treatment Test Sensitivity Specificity Cost Comment Aptima TMA +4 (98%) +3 (98%) $$$ NAAT (like GC/Ct) • Recommended regimen Culture +3 (83%) +4 (100%) $$$ Not in most labs – Metronidazole 2 grams PO single dose Point of care – Tinidazole 2 grams PO single dose •Affirm VP III +3 +4 $$$ DNA probe • Alternative regimen (preferred for HIV infected
    [Show full text]
  • LNG-IUS) in Patients Affected by Menometrorrhagia, Dysmenorrhea and Adenomimyois: Clinical and Ultrasonographic Reports
    European Review for Medical and Pharmacological Sciences 2021; 25: 3432-3439 The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports F. COSTANZI, M.P. DE MARCO, C. COLOMBRINO, M. CIANCIA, F. TORCIA, I. RUSCITO, F. BELLATI, A. FREGA, G. COZZA, D. CASERTA Department of Surgical and Medical Sciences and Translational Medicine, Sant’Andrea University Hospital, Sapienza University of Rome, Rome, Italy Abstract. – OBJECTIVE: Adenomyosis is p=0.025; p=0.014). The blood loss decreased the consequence of the myometrial invasion significantly in both the cohorts (p<0.001) and by endometrial glands and stroma. Transvag- particularly in adenomyotic patients. Pain relief inal ultrasonography plays a decisive role in was observed in all the patients (p<0.001). the diagnosis and monitoring of this patholo- CONCLUSIONS: LNG-IUS can be considered gy. Our study aims to evaluate the efficacy of an effective treatment for managing symptoms LNG-IUS (Levonorgestrel Releasing Intrauter- and improving uterine morphology. ine System) as medical therapy. We analyzed both clinical symptoms and ultrasonograph- Key Words: ic aspects of menometrorrhagia and dysmen- Benign disease of uterus, Dysmenorrhea, Gyne- orrhea in patients with adenomyosis and the cologic imaging, Leiomyomas of the uterus/adeno- control group. myosis. PATIENTS AND METHODS: A prospective co- hort study was carried out on 28 patients suf- fering from symptomatic adenomyosis treat- ed with LNG-IUS. Adenomyosis was diagnosed Introduction through transvaginal ultrasonography by an ex- pert sonographer. A control group of 27 symp- Adenomyosis is a benign gynecological dis- tomatic patients (menorrhagia and dysmenor- ease with a large variety of clinical manifestation; rhea) without a transvaginal ultrasonograph- the most frequent include menorrhagia, metror- ic diagnosis of adenomyosis was treated in the rhagia, dysmenorrhea and chronic pelvic pain1.
    [Show full text]
  • Association Between Menstrual Disorders and Obesity
    ArchiveInt J School of Health SID. 2018 April; 5(2):e65716. doi: 10.5812/intjsh.65716. Published online 2018 April 17. Research Article Association Between Menstrual Disorders and Obesity-Related Anthropometric Indices in Female High School Students: A Cross-Sectional Study Mostafa Rad,1 Marzieh Torkmannejad Sabzevary,2 and Zahra Mohebbi Dehnavi3,* 1Faculty of Nursing and Midwifery, Sabzevar University of Medical Sciences, Sabzevar, IR Iran 2Mobini Hospital, Sabzevar University of Medical Sciences, Sabzevar, IR Iran 3Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, IR Iran *Corresponding author: Zahra Mohebbi Dehnavi, Department of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, IR Iran. Tel: +98-9139752086, E-mail: [email protected] Received 2018 January 02; Revised 2018 April 11; Accepted 2018 April 13. Abstract Background: The menstrual cycle determines the health of women. Menstrual disorders are a major Geneologic problem among women, especially adolescents, which is a major source of anxiety for them and their families. Factors such as BMI, exercise, and stress can be related to menstrual disorders. As a result, this study was conducted to determine the association between menstrual disorders and anthropometric indices in Female High School Students. Methods: This descriptive cross-sectional study was conducted in Sabzevar on 200 high school female students in 2017. The partici- pants first completed the personal, midwifery,
    [Show full text]
  • Impact of Anemia on Menstruation and Academic Performance of Adolescent Girls Attending Secondary Schools of Rural Wardha District 1Rufina Binoy,2 Neema Acharya
    WJOA Impact of Anemia on Menstruation and Academic10.5005/jp-journals-10065-0001 Performance of Adolescent Girls ORIGINAL ARTICLE Impact of Anemia on Menstruation and Academic Performance of Adolescent Girls attending Secondary Schools of Rural Wardha District 1Rufina Binoy,2 Neema Acharya 3 ABSTRACT adolescents, and women of childbearing age group. Anemia is a common nutritional problem in adolescents.4 In this research, we hope to understand the Introduction: Very few studies focus on adolescent girls’ health, in view effect of anemia on the various menstrual parameters and disorders and on the academic performance of adolescent of that the present study was taken up to throw light on girls attending secondary schools of rural Wardha. the prevalence of anemia in the rural district of Wardha Materials and methods: Questionnaires were prepared and and to assess the effect of the same on their menstrual distributed to the female students who came to attend the health and academic performance. adolescent clinic in Acharya Vinoba Bhave Rural Hospital, Sawangi, India, for health checkup. Their hemoglobin was estimated and recorded in their respective questionnaires. MATERIALS AND METHODS Questionnaires were designed to understand in the best way possible the effects of anemia on the menstrual health and • Site: The research was conducted in Acharya Vinoba academic life of the adolescent girls. Bhave Rural Hospital (AVBRH), Sawangi, Wardha, Results: The results revealed a remarkable correlation India. between the grades of anemia and poor menstrual health; a • Type of study: Questionnaire-based study similar result was seen in case of academic performance as • Duration: 6 months well.
    [Show full text]
  • Epidemiology of Menstrual Disorders in Developing Countries: a Systematic Review
    BJOG: an International Journal of Obstetrics and Gynaecology DOI: 10.1046/j.1471-0528.2003.00012.x January 2004, Vol. 111, pp. 6–16 REVIEW Epidemiology of menstrual disorders in developing countries: a systematic review Introduction Information on the prevalence of menstrual complaints in the past three months was obtained in seven countries In developing countries, priority setting in the health (Table 1). These data permit cross national comparisons sector traditionally focuses on the principal causes of mor- in so far as similar questions with a similar time reference tality. More recently, the Global Burden of Disease approach were asked. However, no definitions were provided and incorporates assessment of morbidity and quality of life in considerable variation in the interpretation of questions identifying priorities. Yet, although investigations in various among individuals and across cultures is likely. developing countries reveal that women are concerned by Approximately a dozen subsequent surveys, including menstrual disorders, little attention is paid to understanding community-based, clinic-based and one national census, or ameliorating women’s menstrual complaints.1 Menstrual include some information on menstrual morbidities6–29 dysfunction, like other aspects of sexual and reproductive (Table 2). A few health surveys of special populations, health, is not included in the Global Burden of Disease such as factory workers in Vietnam17 and medical students estimates2,3 and, even as reproductive health programs in Venezuela,27,28 have also included relevant questions expand their focus to address gynaecologic morbidity, the on menstrual disorders. These surveys vary consider- utility of evaluating and treating menstrual problems is ably in the definition of and reference period for men- not generally considered.
    [Show full text]
  • Changes Before the Change1.06 MB
    Changes before the Change Perimenopausal bleeding Although some women may abruptly stop having periods leading up to the menopause, many will notice changes in patterns and irregular bleeding. Whilst this can be a natural phase in your life, it may be important to see your healthcare professional to rule out other health conditions if other worrying symptoms occur. For further information visit www.imsociety.org International Menopause Society, PO Box 751, Cornwall TR2 4WD Tel: +44 01726 884 221 Email: [email protected] Changes before the Change Perimenopausal bleeding What is menopause? Strictly defined, menopause is the last menstrual period. It defines the end of a woman’s reproductive years as her ovaries run out of eggs. Now the cells in the ovary are producing less and less hormones and menstruation eventually stops. What is perimenopause? On average, the perimenopause can last one to four years. It is the period of time preceding and just after the menopause itself. In industrialized countries, the median age of onset of the perimenopause is 47.5 years. However, this is highly variable. It is important to note that menopause itself occurs on average at age 51 and can occur between ages 45 to 55. Actually the time to one’s last menstrual period is defined as the perimenopausal transition. Often the transition can even last longer, five to seven years. What hormonal changes occur during the perimenopause? When a woman cycles, she produces two major hormones, Estrogen and Progesterone. Both of these hormones come from the cells surrounding the eggs. Estrogen is needed for the uterine lining to grow and Progesterone is produced when the egg is released at ovulation.
    [Show full text]
  • Abnormal Uterine Bleeding: a Management Algorithm
    J Am Board Fam Med: first published as 10.3122/jabfm.19.6.590 on 7 November 2006. Downloaded from EVIDENCED-BASED CLINICAL MEDICINE Abnormal Uterine Bleeding: A Management Algorithm John W. Ely, MD, MSPH, Colleen M. Kennedy, MD, MS, Elizabeth C. Clark, MD, MPH, and Noelle C. Bowdler, MD Abnormal uterine bleeding is a common problem, and its management can be complex. Because of this complexity, concise guidelines have been difficult to develop. We constructed a concise but comprehen- sive algorithm for the management of abnormal uterine bleeding between menarche and menopause that was based on a systematic review of the literature as well as the actual management of patients seen in a gynecology clinic. We started by drafting an algorithm that was based on a MEDLINE search for rel- evant reviews and original research. We compared this algorithm to the actual care provided to a ran- dom sample of 100 women with abnormal bleeding who were seen in a university gynecology clinic. Discrepancies between the algorithm and actual care were discussed during audiotaped meetings among the 4 investigators (2 family physicians and 2 gynecologists). The audiotapes were used to revise the algorithm. After 3 iterations of this process (total of 300 patients), we agreed on a final algorithm that generally followed the practices we observed, while maintaining consistency with the evidence. In clinic, the gynecologists categorized the patient’s bleeding pattern into 1 of 4 types: irregular bleeding, heavy but regular bleeding (menorrhagia), severe acute bleeding, and abnormal bleeding associated with a contraceptive method. Subsequent management involved both diagnostic and treatment interven- tions, which often occurred simultaneously.
    [Show full text]